Molecular Medicine Group

Business Services · United Kingdom · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Guildford, Surrey, United Kingdom

Phone Number

+44 1483686390

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Molecular Medicine Group

The University of Surrey Molecular Medicine Group, led by Professor John McVey, focuses on research related to blood coagulation and its implications in both normal physiology and disease pathophysiology. Their work includes studies on the initiation of blood coagulation in disease models, the development of novel anticoagulant strategies, and gene therapy for inherited coagulation factor disorders. The group aims to address issues related to bleeding disorders such as hemophilia and the pathological consequences of inappropriate coagulation, which are significant contributors to cardiovascular disease. Their intended clients include the medical research community and healthcare professionals involved in cardiovascular health and coagulation disorders.Explore more
Molecular Medicine Group's Social MediaPopular SearchesMolecular Medicine GroupSIC Code 87,873NAICS Code 54,541Show more

Is Molecular Medicine Group your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Molecular Medicine Group

Compare insights from companies similar to Molecular Medicine Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Molecular Medicine Group

<$5M
1-10
Private
-
-
N/A
$10.1M
11-50
Private
-
1997
AS
Amanda SloteResearch Communications Administrator
<$5M
1-10
Private
-
2019
N/A
<$5M
1-10
Private
-
2021
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2014
N/A
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Molecular Medicine Group is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Molecular Medicine Group is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Molecular Medicine Group.

Molecular Medicine Group Tech Stack

A closer look at the technologies used by Molecular Medicine Group

Top Business Services Companies

Frequently Asked Questions Regarding Molecular Medicine Group

What is Molecular Medicine Group's official website?
Molecular Medicine Group's official website is www.themcveylab.com
What is Molecular Medicine Group's Revenue?
Molecular Medicine Group's revenue is <$5 Million
What is Molecular Medicine Group's SIC code?
Molecular Medicine Group's SIC: 87,873
What is Molecular Medicine Group's NAICS code?
Molecular Medicine Group's NAICS: 54,541
How many employees does Molecular Medicine Group have?
Molecular Medicine Group has 1-10 employees
What industry does Molecular Medicine Group belong to?
Molecular Medicine Group is in the industry of: Business Services, Research & Development
What is Molecular Medicine Group competition?
Molecular Medicine Group top competitors include: EarlyBird Diabetes Trust, One Nucleus, SynaptixBio, ASCAST: Academic Studies. Caribbean Applied Science and Technology
What technology does Molecular Medicine Group use?
Some of the popular technologies that Molecular Medicine Group uses are: Google Cloud Web Serving, Google Cloud Platform, SiteGround Email Hosting
How do I contact Molecular Medicine Group?
Molecular Medicine Group contact info: Phone number: +44 1483686390 Website: www.themcveylab.com
What does Molecular Medicine Group do?

The University of Surrey Molecular Medicine Group, led by Professor John McVey, focuses on research related to blood coagulation and its implications in both normal physiology and disease pathophysiology. Their work includes studies on the initiation of blood coagulation in disease models, the development of novel anticoagulant strategies, and gene... therapy for inherited coagulation factor disorders. The group aims to address issues related to bleeding disorders such as hemophilia and the pathological consequences of inappropriate coagulation, which are significant contributors to cardiovascular disease. Their intended clients include the medical research community and healthcare professionals involved in cardiovascular health and coagulation disorders.Read More

What are Molecular Medicine Group social media links?
Molecular Medicine Group Twitter page
Is Molecular Medicine Group a public company?
Molecular Medicine Group is private company therefore does not currently have an official ticker symbol
See more information about Molecular Medicine Group

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.